Tissue engineering,g ene therapy, drug screening, and emerging regenerative medicine therapies are fundamentally reliant on high-quality adherent cell culture,b ut current methods to cryopreserve cells in this format can give lowc ell yields and require large volumes of solvent "antifreezes". Herein, we report polyproline as am inimum (bio)synthetic mimic of antifreezep roteins that is accessible by solution, solid-phase,a nd recombinant methods.W ed emonstrate that polyproline has ice recrystallisation inhibition activity linked to its amphipathic helix and that it enhances the DMSO cryopreservation of adherent cell lines.P olyproline mayb e av ersatile additive in the emerging field of macromolecular cryoprotectants.
Tissue engineering,g ene therapy,t herapeutic protein production, and transplantation rely on the successful storage and transport of donor cells. [1] Forexample,inthe production of therapeutic proteins,aspecific cell line must be developed for each protein. [2] Given that any in vitro culture will undergo phenotypic and genotypic changes when propagated for long periods of time,itisneither possible nor practical to maintain ac ontinuous culture of cells. [3] Theonly solution to this is the cryopreservation of cells using significant volumes of cryoprotectants,s uch as DMSO (dimethyl sulfoxide), which are intrinsically toxic. [4] Ther epeated use of DMSO has an impact on the epigenetic profile of cells,specifically the alteration of DNAm ethylation profiles,w hich results in phenotypic changes. [5, 6] There is ar eal need for robust methods to cryopreserve cells in monolayer (adhered to tissue culture scaffolds) format to provide phenotypically identical cells for assays,o bviating the need for replating between freeze-thaw cycles.F ormulations containing 5-10 % DMSO reduce cryoinjury by moderating the increase in solute concentration during freezing [7] [8] [9] but for adhered embryonic stem cells,t heir use results in just 5% cell recovery. [10, 11] Ak ey contributor to cell death during cryopreservation is ice recrystallisation (growth) and additives that can inhibit recrystallisation have the potential to redefine cell storage and hence biomedicine.
Antifreeze (glyco)proteins (AF(G)Ps) are potent ice recrystallisation inhibitors (IRIs), but are unsuitable for cryopreservation applications owing to their potential toxicity/immunogenicity and their secondary effect of dynamic ice shaping (DIS), which leads to needle-like ice crystals that pierce cell membranes. [12] Synthetic polymers that are potent IRIs have emerged as new tools for controlling ice growth. [13] Themost studied one is poly(vinyl alcohol) (PVA), which can inhibit ice growth at concentrations below 0.1 mg mL À1 and enhances the cryopreservation of cells in suspension. [14] [15] [16] It is hypothesized that the activity of PVAi sr elated to its regularly spaced hydroxyl groups. [17] Matsumura and Hyon have developed polyampholytes [18] that are cryoprotective but have moderate IRI activity. [19, 20] Wang and co-workers have demonstrated the significant IRI activity of graphene oxide. [21] Ben and co-workers have developed low-molecular-weight surfactants that also inhibit ice growth. [22] Amajor setback is that the above synthetic IRIs are neither biodegradable nor bioresorbable and have not been applied to the significant challenge of cell monolayer storage.
There are no crystal structures for AFGPs but solutionstate NMR and circular dichroism (CD) spectroscopy suggest ap olyproline II (PP II)-type helix. [23] Polyproline is unique amongst the canonical amino acids in that it has no amide NÀH, meaning that it cannot form intramolecular hydrogen bonds.Therefore,itiswater-soluble and quite hydrophobic at the same time,a si st he case for AFP I, which contains 70 % alanine (a hydrophobic amino acid). We thus hypothesised that polyproline could be aminimal AF(G)P mimic owing to its amphiphilicity. [24] Homopolypeptides are appealing targets compared to vinyl polymers as they can be prepared by solidphase synthesis, [25] solution-phase polymerisation, [26] or recombinant methods, [27] proving vast (bio)synthetic space.
Herein, we introduce polyproline as am inimum (bio)synthetic antifreeze protein mimic. We demonstrate that polyproline has ice recrystallisation inhibition activity,w hich is linked to its amphipathic PP II helix structure.P olyproline was found to improve the post-cryopreservation recovery of cell monolayers compared to DMSO alone,d emonstrating an ew macromolecular approach for the storage of complex cells to enable next-generation therapies.
l-, d-, and (racemic) d/l-polyproline were synthesised by condensation polymerisation using 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC,S cheme 1), alongside several commercial samples.F ollowing dialysis,t he polymers were characterised by size exclusion chromatography (SEC; Table 1 ). Thep olymers were less disperse than expected owing to fractionation during dialysis.
CD spectroscopy confirmed that PPro 15 adopted aP PII helix ( Figure 1A ;s ee also the Supporting Information, Figure S1) [31] with characteristic signals present at 207 and 228 nm, whilst ar andom coil would exhibit slight peak shifting, with signals absent in the 220 nm region. [32] P(d-Pro) 15 gave the mirror spectrum whilst the d/l racemic mixture showed no secondary structure.T his series of peptides were subsequently tested for IRI activity using asplat assay. [33] This involved seeding alarge number of small ice crystals,w hich were annealed for 30 min at À8 8 8Cb efore being photographed. Thea verage crystal size was measured relative to aPBS control, with smaller values indicating more IRI activity ( Figure 1B ,C).
All polyproline variants were found to display dosedependent activity but weak molecular-weight dependence in the range tested ( Figure 1B ). Thes hortest peptide (PPro 10 ) lost activity below 10 mg mL À1 ,b ut the longer ones retained activity at 5mgmL À1 .T he magnitude of activity was significantly smaller than for AF(G)Ps,w hich function at concentrations as low as 0.14 mgmL À1 , [34] but comparable to that of polyampholytes. [19, 20] Knight and co-workers have observed that poly(hydroxyproline) has IRI activity,w hich was assumed to be due to the regularly spaced hydroxyl groups along the backbone. [35] However, the observations made here suggest that the PP II helix, rather than (or in addition to) the hydroxyl groups,gives rise to the observed activity. Figure 1C compares the IRI activity of poly(hydroxyproline) with those of PPro 15 and two a-helical poly(amino acid)s. [36] Polylysine (PLys 50 )a nd poly(glutamic acid) (PGlu 110 )s howed no IRI activity.P Pro 15 was found to be more active than poly(hydroxyproline) of higher molecular weight. This finding confirmed that hydroxyl groups are not essential for activity in IRI-active compounds.P ( d-Pro 15 )a nd P(d/l-Pro 21 )h ad statistically identical activity to PPro 15 ,s uggesting that local rather than long-range order is crucial for activity.
We hypothesise that IRI activity requires segregated hydrophilic and hydrophobic domains (amphipathy). [37, 22, 24] PPro 10 was compared to an on-glycosylated type Is culpin AFP [38] and also to PGlu 10 by mapping their hydrophobic/ hydrophilic domains ( Figure 2 ). Thet ype Is culpin AFP (Figure 2A )p ossesses "patches" of hydrophobic/hydrophilic groups.P Pro 10 ( Figure 2B )a lso possesses this facial amphi-Scheme 1. Condensation polymerisation of proline. The materials were used in stereopure form but both the l-and d-isomers were used, hence no stereocentres are shown. 
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Zuschriften philicity.Incomparison, PGlu 10 (no IRI activity) has charged groups around the core of the helix, which prevents the presentation of hydrophobic domains.T his agrees with our previous study on nisin A, which has IRI activity associated with segregated domains, [37] and also the results obtained with amphiphiles developed by Ben et al.,w hich only function below the critical micelle concentration. [22] Aside from IRI activity,A F(G)Ps display unwanted ice shaping,w hich promotes the formation of needle-like ice crystals,w hich damage cell membranes. [12] Cryo-confocal microcapillary microscopy has emerged as at ool for monitoring ice crystal shaping, [39] and was also employed here (Figure 3) . Anon-IRI-active dye,sulforhodamine B, provided contrast against the ice (which appears dark). Acontrol using pure PBS showed no shaping whilst zirconium acetate (ZrAc), which is as trong ice shaper, produced hexagonal crystals. [39] PPro 19 did not induce shaping, supporting the concept that polyproline inhibits ice crystal growth without inhibiting the formation of aspecific plane of ice;however,as these are relatively weak IRIs,the concentrations needed for ice shaping would be very high.
To explore polyproline as am acromolecular cryopreservative,A 549 cells were employed as ap rototypical adherent cell line. [40] Theprotective osmolyte proline (which has no IRI activity;s ee the Supporting Information) was used as as econdary cryoprotectant. A549 cells were incubated with 200 mm (23 mg mL À1 )proline (blue bars; Figure 4 ) or medium alone (red bars;F igure 4) for 24 h. Them edium was then removed and replaced with am edium containing 10 % DMSO with varying concentrations of PPro 11 (1250 gmol À1 , = 1.03). After 10 min exposure to this solution, all excess solvent was removed, and the cells were subjected to controlled-rate freezing at 1 8 8Cmin À1 to À80 8 8C. Following storage at À80 8 8C, the cells were thawed by addition of warm medium (37 8 8C), and the total number of viable cells was determined by trypan blue staining 24 ha fter thawing. Figure 4s hows that the use of DMSO alone led to 27 %c ell recovery.Addition of polyproline alone to 10 %DMSO failed to give any additional protection. However,for cells that had been preconditioned with 200 mm proline for 24 hb efore treatment with 10 mg mL À1 PPro 11 /10 %D MSO,t he cell recovery doubled to 53 %. Increasing the concentration of polyproline beyond 10 mg mL À1 did not increase recovery further, suggesting that the additive benefits plateau at 10 mg mL À1 . [14] It should be highlighted that the cell viability assays measure intact cells,a nd that detailed functional analysis will be needed in the future for demonstration of complex function. Forc omparison with other macromolecular cryopreservatives,M atsumura and co-workers have reported poly(ampholyte)-enhanced monolayer storage using vitrification solutions,g iving near-quantitative cell recovery. [41] However,t his required very high DMSO concentrations of 6.5 m (> 500 mg mL À1 )p lus 10 wt %( ca. 100 mg mL À1 )o ft he polymer,a nd there was ar eduction in the post-thaw proliferation rate associated with the large solvent volumes,which may limit practical applications.Inour PPro system introduced here,t he total recovery levels were less,b ut far lower concentrations of DMSO were employed (10 wt %/ca. 100 mg mL À1 ), and the total exposure time to this potentially toxic component was only 10 min. To critically compare PPro,another batch (PPro 10-25 )was synthesised and tested for cytotoxicity and heamocompatibility.A 549 monolayers were exposed to PPro for 24 h, and the cell viability was assessed (see the Supporting Information). This extended exposure period led to areduction in alamar blue to 60 %for 5mgmL À1 PPro,s uggesting some cytotoxicity if exposed to elevated concentrations for long periods of time.I ti s important to note that in this cryopreservation procedure, PPro is only in contact with the cells for 10 min before the excess is removed and the cells are frozen. Red blood cell heamolysis experiments (see the Supporting Information) 
Zuschriften showed this was not due to any inherent membrane activity of the (amphipathic) PPro.
In summary,w eh ave demonstrated that polyproline is ap otent additive for cell-monolayer cryopreservation when appropriate freezing conditions are employed. Polyproline has moderate ice recrystallisation inhibition activity,w hich was hypothesised to be due to its "patchy" amphipathic structure associated with its PP II helix. Addition of polyproline to adherent cell cultures led to an increase from 20 %to > 50 %i nt otal cell recovery post-cryopreservation, which is significantly better than for the use of DMSO alone.T his increase in recovery is thought to be associated with the inhibition of ice recrystallisation. Short exposure times of just 10 min to the polyproline/DMSO solution, followed by removal of the excess solvent, reduced the cytotoxicity associated with long-term (24 h) exposure to elevated levels of polyproline.The minimal solvent exposure times may give benefits in downstream processing and biomedical applications compared to current high-solvent-concentrationm ethods using vitrification. Polyproline is appealing compared to other macromolecular cryoprotectants as it only comprises native amino acids and can be obtained by chemical and biochemical methods.
